Oak Harbor Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.9K Hold
189
0.01% 178
2026
Q1
$31.9K Sell
189
-4
-2% -$684 0.01% 235
2025
Q4
$32.6K Buy
193
+4
+2% +$650 0.01% 230
2025
Q3
$27.3K Hold
189
0.01% 225
2025
Q2
$23.9K Hold
189
0.01% 221
2025
Q1
$24.2K Hold
189
0.01% 228
2024
Q4
$25K Hold
189
0.01% 204
2024
Q3
$27.5K Hold
189
0.01% 198
2024
Q2
$25.9K Hold
189
0.01% 195
2024
Q1
$25.9K Hold
189
0.01% 200
2023
Q4
$25.7K Hold
189
0.01% 197
2023
Q3
$23.1K Hold
189
0.01% 198
2023
Q2
$24K Hold
189
0.01% 206
2023
Q1
$24.4K Hold
189
0.01% 199
2022
Q4
$24.8K Hold
189
0.01% 194
2022
Q3
$22K Hold
189
0.01% 190
2022
Q2
$22K Hold
189
0.01% 188
2022
Q1
$25K Hold
189
0.01% 201
2021
Q4
$29K Buy
+189
New +$29.3K 0.01% 206

Other funds holding IBB

Oak Harbor Wealth Partners's IBB Position: Q2 2026 in Review

Oak Harbor Wealth Partners held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 189 shares worth $35.9K. The position accounts for 0.01% of the portfolio, ranked #178.

Oak Harbor Wealth Partners first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Oak Harbor Wealth Partners held 189 shares of iShares Biotechnology ETF worth $35.9K as of Q2 2026.
  • Oak Harbor Wealth Partners left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Oak Harbor Wealth Partners's portfolio in Q2 2026, its #178 holding.
  • Oak Harbor Wealth Partners first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Oak Harbor Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.